For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income ...

The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.

JPMorgan has identified four large-cap U.S. pharmaceutical stocks it expects to perform strongly in 2026, citing a favorable ...

Discover S&P 500 forecasts for 2025-2026, key market risks, and why pharmaceuticals may outperform. Click for more on my view ...

Anti-obesity drugs are being considered for a range of addictive behaviors. Pfizer just acquired a next-generation, clinical-stage maker of obesity treatments. You could make a strong argument that it ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

Don’t buy a stock, buy a business, says our headline. It’s not as easy as it sounds. But it’s not too difficult either. While there are several ways to identify a good business, keep this one in mind: ...

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

Nigeria’s listed pharmaceutical companies have quietly delivered some of the strongest equity returns on the Nigerian ...